Bioventus Tangible Assets Book Value per Share from 2010 to 2024
| BVS Stock | USD 4.31 0.02 0.47% |
Check Bioventus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioventus main balance sheet or income statement drivers, such as Depreciation And Amortization of 41.5 M, Interest Expense of 42.7 M or Total Revenue of 386.8 M, as well as many exotic indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 0.0198 or PTB Ratio of 1.81. Bioventus financial statements analysis is a perfect complement when working with Bioventus Valuation or Volatility modules.
Bioventus | Tangible Assets Book Value per Share |
About Bioventus Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Bioventus income statement, its balance sheet, and the statement of cash flows. Bioventus investors use historical funamental indicators, such as Bioventus's Tangible Assets Book Value per Share, to determine how well the company is positioned to perform in the future. Although Bioventus investors may use each financial statement separately, they are all related. The changes in Bioventus's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bioventus's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bioventus Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bioventus. Please read more on our technical analysis and fundamental analysis pages.
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the bodys natural healing process in the United States and internationally. The company was founded in 2011 and is headquartered in Durham, North Carolina. Bioventus Inc operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1160 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bioventus in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bioventus' short interest history, or implied volatility extrapolated from Bioventus options trading.
Pair Trading with Bioventus
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioventus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioventus will appreciate offsetting losses from the drop in the long position's value.Moving together with Bioventus Stock
| 0.81 | FORA | Forian Inc Financial Report 10th of May 2024 | PairCorr |
Moving against Bioventus Stock
| 0.69 | ICCM | Icecure Medical Financial Report 27th of May 2024 | PairCorr |
| 0.58 | SIBN | Si Bone Financial Report 6th of May 2024 | PairCorr |
| 0.51 | GH | Guardant Health Financial Report 14th of May 2024 | PairCorr |
| 0.42 | SRDX | SurModics Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Bioventus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioventus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioventus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioventus to buy it.
The correlation of Bioventus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioventus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioventus moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioventus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Bioventus Correlation against competitors. For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Bioventus Stock analysis
When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world |
Is Bioventus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioventus. If investors know Bioventus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioventus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.54) | Revenue Per Share 8.178 | Quarterly Revenue Growth 0.076 | Return On Assets 0.0012 | Return On Equity (0.38) |
The market value of Bioventus is measured differently than its book value, which is the value of Bioventus that is recorded on the company's balance sheet. Investors also form their own opinion of Bioventus' value that differs from its market value or its book value, called intrinsic value, which is Bioventus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioventus' market value can be influenced by many factors that don't directly affect Bioventus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioventus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioventus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioventus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.